Insider Shareholders with Direct Ownership of Cara Therapeutics, Inc. (CARA)
This section provides a comprehensive overview of the insiders with direct ownership of Cara Therapeutics, Inc. (CARA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cara Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Derek T Chalmers
President & CEO |
116,834 | 78,649 | 991,405 $297,421 | 14 |
Sep 07, 2021
Reduced 1.98%
|
| 416,047 | 25,440 | 411,007 $123,302 | 7 |
Jun 04, 2024
Added 42.3%
|
|
| 202,085 | 0 | 202,085 $60,625 | 4 |
Jun 04, 2024
Added 42.71%
|
|
| 204,585 | 14,300 | 198,485 $59,545 | 8 |
Jun 04, 2024
Added 43.15%
|
|
| 183,009 | 0 | 183,009 $54,902 | 2 |
Jun 04, 2024
Added 45.15%
|
|
|
Christopher Posner
PRESIDENT AND CEO |
256,641 | 97,405 | 172,436 $51,730 | 18 |
Aug 01, 2024
Reduced 2.35%
|
|
Frederique Ph.D. Menzaghi
CHIEF SCIENTIFIC OFF,SVP-R&D |
97,707 | 34,952 | 167,247 $50,174 | 18 |
Feb 01, 2024
Added 7.47%
|
| 150,647 | 0 | 150,647 $45,194 | 1 |
Jun 04, 2024
Added 50.0%
|
|
|
Scott Terrillion
SEC'Y; CHIEF COMPLIANCE & G.C. |
93,662 | 43,797 | 88,247 $26,474 | 23 |
Apr 05, 2024
Reduced 3.03%
|
|
Harrison M Bains Jr
Director |
51,438 | 7,200 | 57,438 $17,231 | 4 |
Jun 01, 2023
Added 36.04%
|
|
Joana Goncalves
CHIEF MEDICAL OFFICER |
86,507 | 68,515 | 53,365 $16,009 | 34 |
Apr 05, 2024
Reduced 4.91%
|
|
Thomas Charles Reilly
Chief Financial Officer |
41,837 | 4,026 | 37,811 $11,343 | 6 |
Mar 03, 2022
Reduced 5.13%
|
|
Richard Makara
VP, Head of Accting;Controller |
7,500 | 0 | 13,583 $4,074 | 1 |
Jun 15, 2022
Added 35.57%
|
|
Ryan D Maynard
CHIEF FINANCIAL OFFICER |
13,500 | 5,488 | 13,500 $4,050 | 2 |
Feb 01, 2024
Added 50.0%
|